LIVN

LIVN

LivaNova PLC Ordinary Shares

$46.630+-0.000 (-0.000%)

Preço em tempo real

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$46.630

Máximo

$46.630

Mínimo

$46.630

Volume

0.67M

Fundamentos da empresa

Estatísticas de negociação

Notícias relacionadas

BusinessWire

CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced

Ver mais
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
BusinessWire

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS

Ver mais
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Analyst Upgrades

Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target

Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.

Ver mais
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target